Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis (vol 375, pg 555, 2010)

被引:0
|
作者
Glasier, A. F.
Cameron, S. T.
Fine, P. M.
机构
来源
LANCET | 2014年 / 384卷 / 9953期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1504 / 1504
页数:1
相关论文
共 50 条
  • [1] Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis
    Glasier, Anna F.
    Cameron, Sharon T.
    Fine, Paul M.
    Logan, Susan J. S.
    Casale, William
    Van Horn, Jennifer
    Sogor, Laszlo
    Blithe, Diana L.
    Scherrer, Bruno
    Mathe, Henri
    Jaspart, Amelie
    Ulmann, Andre
    Gainer, Erin
    [J]. LANCET, 2010, 375 (9714): : 555 - 562
  • [2] THE LEVONORGESTREL VS. COPPER INTRAUTERINE DEVICE FOR EMERGENCY CONTRACEPTION: A NON-INFERIORITY RANDOMIZED CONTROLLED TRIAL
    Turok, D.
    Gero, A.
    Simmons, R.
    Kaiser, J.
    Stoddard, G.
    Sexsmith, C.
    Gawron, L.
    Sanders, J.
    [J]. CONTRACEPTION, 2020, 102 (04) : 274 - 274
  • [3] Systematic Review and Meta-Analysis to Estimate the Treatment Effect and Inform a Non-Inferiority Margin for a Phase 3 Non-Inferiority Trial in Uncomplicated Urogenital Gonorrhea
    Mitrani-Gold, Fanny S.
    Fix, Jonathan
    Donald, Alison
    [J]. SEXUALLY TRANSMITTED DISEASES, 2022, 49 (10S) : S75 - S76
  • [4] A telemedicine model for abortion in South Africa: a randomised, controlled, non-inferiority trial (vol 400, pg 670, 2022)
    Endler, M.
    Petro, G.
    Gemzell, Danielsson K. G.
    [J]. LANCET, 2022, 400 (10359): : 1194 - 1194
  • [5] Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial (vol 376, pg 91, 2010)
    Vaidya, J. S.
    Joseph, D. J.
    Tobias, J. S.
    [J]. LANCET, 2010, 376 (9735): : 90 - 90
  • [6] Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial (vol 376, pg 33, 2010)
    Sanne, Ian
    [J]. LANCET, 2010, 376 (9746): : 1054 - 1054
  • [7] Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial (vol 397, pg 499, 2021)
    Maertens, J. A.
    Rahav, G.
    Lee, D-G
    [J]. LANCET, 2021, 398 (10299): : 490 - 490
  • [8] Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial (vol 389, pg 1630, 2017)
    Williams, H. C.
    Wojnarowska, F.
    Kirtschig, G.
    [J]. LANCET, 2017, 390 (10106): : 1948 - 1948
  • [9] Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial (vol 399, pg 1790, 2022)
    Trutnovsky, G.
    Reich, O.
    Joura, E. A.
    [J]. LANCET, 2022, 400 (10359): : 1194 - 1194
  • [10] Conservative management versus invasive management of significant traumatic pneumothoraces in the emergency department (the CoMiTED trial): a study protocol for a randomised non-inferiority trial
    Blythe, Nicola M.
    Coates, Katherine
    Benger, Jonathan R.
    Annaw, Ammar
    Banks, Jonathan
    Clement, Clare
    Clout, Madeleine
    Edwards, Antoinette
    Gaunt, Daisy
    Kandiyali, Rebecca
    Lane, J. Athene
    Lecky, Fiona
    Maskell, Nick A.
    Metcalfe, Chris
    Platt, Marie
    Rees, Sophie
    Taylor, Jodi
    Thompson, Julian
    Walker, Steven
    West, Douglas
    Carlton, Edward
    [J]. BMJ OPEN, 2024, 14 (06):